InvestorsHub Logo

biopharm

08/05/18 11:35 PM

#327826 RE: biopharm #306154

What changes have Ziopharm made after patient deaths, especially with Dr Jedd Wolchok on board with Ziopharm and knowing PS Targeting reduces off Target toxicities ?



I do believe Hagop Youssoufian was leading Ziopharm and close ties to Dr Jedd Wolchok....now leading along with Oncologie and PS Targeting IP

Tomorrow would be a good day for more news from Avid